The use of two plasma derived factor VIII concentrates in type 2 a von Willebrand's disease (VWD).

被引：0
|
作者：
Hampton, KK [1 ]
Makris, M [1 ]
机构：
[1] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4103
引用
收藏
页码：99B / 99B
页数：1
相关论文
共 50 条
  • [41] Prophylaxis and von Willebrand's disease (vWD)
    Abshire, Thomas C.
    THROMBOSIS RESEARCH, 2006, 118 : S3 - S7
  • [42] Type 1 von Willebrand's disease is often associated with mutations in the factor VIII binding region of von Willebrand factor
    Jenkins, PV
    Ononye, C
    Murdock, PJ
    Pasi, KJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 76 - 76
  • [43] Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test
    Mori, Filippo
    Rossi, Paola
    Nardini, Ilaria
    Gambelli, Davide
    Farina, Claudio
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (03) : 221 - 228
  • [44] The challenging management of a child with type 3 von Willebrand disease (VWD) and antibodies to von Willebrand factor (VWF)
    Platokouki, H.
    Pergantou, H.
    Xafaki, P.
    Adamtziki, E.
    HAEMOPHILIA, 2012, 18 : 44 - 44
  • [45] Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease: A Systematic Review and Pharmacovigilance Update
    Ettingshausen, Carmen Escuriola
    Lassila, Riitta
    Escolar, Gines
    Male, Christoph
    Schirner, Kathrin
    Heyder, Lisa
    Berntorp, Erik
    HAEMOPHILIA, 2025, 31 (02) : 247 - 262
  • [46] Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/ Factor VIII Concentrate in Previously Treated Patients with Von Willebrand Disease
    Sidonio, Robert F., Jr.
    Boban, Ana
    Dubey, Leonid
    Inati, Adlette
    Kiss, Csongor
    Lissitchkov, Toshko
    Novik, Dzmitry
    Peteva, Elina
    Taher, Ali T.
    Timofeeva, Margarita Arkadevna
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Werner, Sylvia
    Knaub, Sigurd
    Khayat, Claudia
    BLOOD, 2022, 140 : 8438 - 8439
  • [47] von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD
    Atiq, Ferdows
    Schutte, Lisette M.
    Looijen, Agnes E. M.
    Boender, Johan
    Cnossen, Marjon H.
    Eikenboom, Jeroen
    de Maat, Moniek P. M.
    Kruip, Marieke J. H. A.
    Leebeek, Frank W. G.
    BLOOD ADVANCES, 2019, 3 (24) : 4147 - 4154
  • [48] Two unrelated von willebrand disease (VWD) type 2A (IIE) families caused by skipping of exon 26 on the von willebrand factor (VWF) mRNA
    Baronciani, L.
    Garcia-Oya, I
    Solimando, M.
    La Marca, S.
    Cozzi, G.
    Stufano, F.
    Canciani, Teresa M.
    Peyvandi, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 913 - 913
  • [49] Characterization of von Willebrand factor and ADAMTS13 in plasma derived factor concentrates
    Konkle, B. A.
    Fletcher, S. N.
    Lannert, K. W.
    Johnsen, J. M.
    Bergman, G. E. G.
    Teramura, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 311 - 312
  • [50] IMPACT OF ANEMIA ON VON WILLEBRAND FACTOR AND FACTOR VIII IN TYPE 1 VON WILLEBRAND DISEASE AND MILD HEMOPHILIA
    Febres, Maria E. Carter
    Tarango, Cristina
    Fenchel, Matthew
    Pomales, Jennifer
    Mullins, Eric
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E18 - E18
12345